Research & Development: Page 34

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE: Connected Health: An Important Tool for Improving Outcomes

    The digital age has put more data and insights into the hands of healthcare professionals and patients. Digital technologies — wireless, electronic, mobile, telehealth — have made connected health possible, with the objective of enhancing patient engagement and ultimately health outcomes. To dete...

    By PharmaVoice Team • May 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Connected Health — We Could Learn From Marvel Studios

    Marvel Studios is about to release its last Avengers movie. It brings together the biggest superheroes from a myriad of universes for the final epic battle, connecting many storylines for one last big hit. Marvel has done quite a bit over the last 10 years to connect these superhero worlds, throu...

    By Angelo Joseph Campano • May 1, 2019
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HBA Special Feature: The Power of the Network

    The Healthcare Businesswomen’s Association has one of the most influential networks in the industry. The organization has been successful in building powerful communities, including its Rising Star and Luminary honorees, as well as being a valued consultant to many of its corporate partners to gu...

    By PharmaVoice Team • May 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Hackathons and Innovation Hackathons have come a long way since the first reported use of the term back in 1999 when a group of developers came together in Calgary to avoid legal problems due to export regulations of cryptographic software from the United States. Today, hackathons, hackfests, and...

    By Taren Grom • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Let’s talk About Mental Health In Men Otsuka has launched an original video series entitled “Let’s Talk! We’re Better Together" to encourage conversations about mental wellness. Social stigma is an intimidating reality for many people suffering with mental illness, so the last thing one may think...

    By PharmaVoice Team • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    The World’s First Virtual Caregiver Unveiled Trend Watch: Meeting Patient Needs Through Technology SameDay Security, a provider of automated home care solutions and safety devices, unveiled the world’s first virtual caregiver, Addison Care, earlier this year at the annual Computer Electronic Show...

    By PharmaVoice Team • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Genpact Research: AI Adoption Accelerating Trend Watch: AI Applications Grow Across the Healthcare Spectrum The adoption of AI is rapidly growing, however, to take full advantage of AI’s opportunities, businesses must understand and overcome lingering doubts from their customers and employees, ac...

    By PharmaVoice Team • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Restoring the Microbiome Todd Krueger, President and CEO of AOBiome Therapeutics, discusses the company’s research to develop therapies that aim to re-introduce beneficial bacteria to the microbiome. The human microbiome consists of trillions of microorganisms that live in and on humans and are e...

    By Todd Krueger • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Connecting Rare Disease Patients Angie Rowe, Interim Executive Director, Global Genes, talks about the 10th anniversary of the rare disease organization and its vision for the future. PV: Over the past 10 years, what impact has Global Genes had on the rare disease community? Rowe: When Nicole Boi...

    By Angie Rowe • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hacking the Biopharma Industry

    Biopharmaceutical companies and their partners are taking a page from Silicon Valley by sponsoring hackathons and competitions to drive innovation in research and develop new solutions for patients. Pharma companies are reaching outside their own walls to discover innovative new ways to improve t...

    By Denise Myshko • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Wearables In Clinical Trials

    Wearables are improving the clinical trial experience for patients and satisfying the need to collect data for real-world use studies. Experts agree: future drug development will be based on broader, real-time patient data. Connected health, which includes wearable devices and mobile health (mHea...

    By Denise Myshko • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Red Zone: Innovation from the Inside Out

    In November 2018, Cognizant was proud to introduce two new products into the Life Sciences market. Both came out of our Accelerator LaunchPad program, which solicits ideas, creates internal startups, and launches only those products that can survive and thrive throughout its rigorous process. But...

    By Ari Srinivasan • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Agile Transformation By definition change is hard, and anyone who works for a large or even a small company has been through at least one reorganization. The agility that companies will need to compete in the new economy, one defined by the digitization of healthcare, cannot be underestimated, an...

    By Taren Grom • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Harnessing the Power of the Body’s Electrical System Frank Amato, CEO of electroCore, talks about how vagus nerve stimulation can be used for the preventive treatment of cluster headache and for the relief of pain associated with migraine and episodic cluster headache. Our nervous system interact...

    By Frank Amato • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Bayer Uses AI to Boost Pharmacovigilance Trend Watch: Pharma Use of AI Increases In an effort to accelerate its patient safety data monitoring by using artificial intelligence, Bayer has partnered with Genpact to employ its Pharmacovigilance Artificial Intelligence (PVAI) products. These AI tools...

    By PharmaVoice Team • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Transformation: Ready, Set, Agile

    According to McKinsey, companies that have enterprise agility share some commonalities: a North Star-mentality, in other words an overarching customer strategy; a scalable team structure; a rapid decision-making mentality; a dynamic people model that ignites passion; and a willing adoption of nex...

    By PharmaVoice Team • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Red Zone: Disruptive Innovation: Questions for the C-Suite

    It is not the strongest of the species that survives, nor is it the most intelligent. It is the one that is most adaptable to change. Whether a direct quote from Charles Darwin or a summary of his writings, this statement is perhaps the most profound scientific explanation of life itself, in all ...

    By Srini Shankar • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Artificial Intelligence Happy New Year. As we enter 2019, we take note of one of the major trends expected to impact all aspects of the life-sciences industry: artificial intelligence. In 2019, according to Forrester, AI solutions will continue to spread across the healthcare continuum thanks to ...

    By Taren Grom • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Medicinal Theater BioMarin Pharmaceutical and Believe Ltd. sponsored a first-of-its-kind theatrical production for teenagers with hemophilia. The musical, Hemophilia: The Musical, took place at New World Stages on Nov. 12, 2018. Before the performance, students participated in the Breaking Throug...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    Payers Use Healthtech to Improve Patient Outcomes, Lower Costs Trend Watch: Healthtech Mobile App Market Continues To Grow Payers Offer Free Wearables UnitedHealthcare, Aetna, and John Hancock have all implemented programs that offer free Apple Watches to customers, if they exercise daily. The la...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Artificial Intelligence Key to Improving Healthcare Quality, Reducing Costs Trend Watch: AI Implications for Healthcare are Widespread Artificial Intelligence (AI) is key to building a better healthcare future, according to a recent survey of 500 U.S. healthcare leaders on their attitudes and usa...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Modifying the Immune Response in Celiac Leslie Williams, CEO of ImmusanT, discusses the company’s research for developing a disease-modifying therapeutic for patients with celiac disease. Celiac disease is often misunderstood as a lifestyle disease. Unmanaged, celiac can result in chronic anemia,...

    By Leslie Williams • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence: Molecule to Market

    The adoption of artificial intelligence (AI) is rapidly taking hold across global businesses, including the life-sciences industry. AI is typically defined as the ability of a machine to perform cognitive functions associated with human minds, such as perceiving, reasoning, learning, and problem ...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Coming Wave of Cannabis-based Medicines

    Cannabis has remained a source of controversy — from debates on its medicinal value and legalization to concerns about dependency. Cannabis is a hot-button issue among patients, healthcare practitioners, and policymakers. But that is changing. In fact, 32 states and Washington, D.C., now allow ma...

    By Denise Myshko • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The year ahead… As we come to the end of 2018, it’s important to pause and reflect on not just where we’ve been, but where we are going as an industry. In 2018, we saw continuing uncertainty in terms of the Affordable Care Act. We welcomed Alex Azar as the new Secretary of Health and Human Servic...

    By Taren Grom • Nov. 15, 2018